Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neuroimaging Biomarkers in Anxiety and OCD with Paroxetine
NCT03894085Completed
- Sponsor
- Central South University
- Start
- May 2019
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of paroxetine in generalized anxiety disorder (GAD), panic disorder, Social Anxiety Disorder (SAD) and 1 more (5 arms), sponsored by Central South University. Primary endpoints: Structural and Functional MRI Data at 4 weeks, Hamilton Anxiety Rating Scale at 4 weeks and 2 more. Started May 2019; status: completed.
02
Drugs
paroxetine
03
Conditions
generalized anxiety disorder (GAD)panic disorderSocial Anxiety Disorder (SAD)obsessive compulsive disorder (OCD)
Beyond the preview
Go deeper on NCT03894085.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03894085.